about
Genome-wide association study of smoking behaviours in patients with COPDMultidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD.A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency.Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility.NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels.Novel Immune Mechanisms in Hypertension and Cardiovascular Risk.Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction.Th17 responses are not altered by natural exposure to seasonal allergens in pollen-sensitive patients.Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma.Superoxide dismutases, lung function and bronchial responsiveness in a general population.Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.Dietary factors and lung function in the general population: wine and resveratrol intake.Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells.Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors.Heme oxygenase 1 variations and lung function decline in smokers: proof of replicationMBL2 and fever during neutropenia in children with acute lymphoblastic leukaemiaNo effects of EPHX1 polymorphisms on the level or change of FEV1 in the general populationHigher levels of circulating naïve CD8+CD45RA+ cells are associated with lower extent of coronary atherosclerosis and vascular dysfunctionInvolvement of CD8+ T cell subsets in early response to vascular injury in patients with peripheral artery disease in vivoT Cell-Derived miRNA-214 Mediates Perivascular Fibrosis in HypertensionCausal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapyWhite Blood Cells and Blood Pressure: A Mendelian Randomization StudyThe role of chemokine CCL5/RANTES and metalloproteinase-9 as inflammatory modulators in symptomatic internal carotid artery stenosisE-vaporating benefits of e-vapingCardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1Response
P50
Q29417072-A932D0CC-6E9B-46A9-BFB5-78588562FD9BQ33902674-B22DFD65-A273-433D-9BE4-199FB2035A92Q34206203-BE230BF0-B103-4A3E-A684-54DD6FF71D0AQ35816887-FE88E95F-F593-4572-9C7E-446F0A76C864Q36149225-8C2C70D2-01EA-4468-B67D-9357A5EDD1DBQ36691602-63EDAA84-3F34-4437-846B-B8CFCAAF1808Q37175834-017EAF67-D27F-4F6D-88CD-4C65EFB708E7Q37503726-317D1B4F-568C-403C-A7F6-91EAFCAD2B73Q37683209-AB1F40BC-DBCA-4018-9009-B036BE133774Q37690237-4A89BB40-29C9-4125-8DF7-15EC5C334CEFQ39229226-81D15C28-B1AE-487A-A193-E08733AE7D6AQ39579831-C3227F86-AE7A-4DD3-812A-14F5AFF8ABF5Q46123606-E5C13459-845D-4B3F-8E4D-DC21E67EFE1EQ47104825-B9044B80-9BBD-4E9A-9827-21D6470303D4Q50527767-6D365081-8DD0-47D1-B17D-308976F5371FQ51762547-38FD49BE-1DF3-4DEA-8D94-BD1F5920F466Q64928034-34B61AFF-250D-4282-B96F-BD19A7A03017Q81385571-3A241047-A765-4F73-8F76-46F1C017790BQ82329398-F0BB88EF-FD9B-4649-8FA2-EAF62EB988EDQ83270252-3FFB5B66-7815-47BF-BFAC-26C70F34EA0DQ88176556-D9ADC170-EFB5-445B-97E8-73F02D07E47FQ89218939-5D546D65-B7D8-4493-9883-C902CA1B4220Q89740991-DF234180-DE38-4E70-A2AE-47BA584B8754Q90027194-BADB5131-C7AC-4E1F-8079-E31434368B33Q90143156-3372B33F-C173-466C-BCCE-577EE320743DQ90901185-37579354-3675-4D91-AC03-3F5CA0A23AD0Q91713615-1D35E3EA-E270-4BB9-A72B-034F19816D87Q91987494-CAD4CB06-B5F3-477C-91F2-931FA3576AE7Q95504739-CA4FC149-EF61-4D77-A9A6-0F490D785CC4
P50
description
onderzoeker
@nl
polski biolog, (biologia medyczna)
@pl
researcher, ORCID id # 0000-0001-7682-6122
@en
name
Mateusz Siedlinski
@ast
Mateusz Siedlinski
@en
Mateusz Siedlinski
@es
Mateusz Siedlinski
@nl
Mateusz Siedliński
@pl
type
label
Mateusz Siedlinski
@ast
Mateusz Siedlinski
@en
Mateusz Siedlinski
@es
Mateusz Siedlinski
@nl
Mateusz Siedliński
@pl
prefLabel
Mateusz Siedlinski
@ast
Mateusz Siedlinski
@en
Mateusz Siedlinski
@es
Mateusz Siedlinski
@nl
Mateusz Siedliński
@pl
P106
P1153
24449667000
P31
P3124
P496
0000-0001-7682-6122